- Home
- POCI vs CVKD Comparison
POCI vs CVKD Comparison
Compare POCI & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POCI
- CVKD
- Stock Information
- Founded
- POCI 1982
- CVKD 2022
- Country
- POCI United States
- CVKD United States
- Employees
- POCI N/A
- CVKD N/A
- Industry
- POCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- POCI Health Care
- CVKD Health Care
- Exchange
- POCI Nasdaq
- CVKD Nasdaq
- Market Cap
- POCI 35.1M
- CVKD 29.5M
- IPO Year
- POCI N/A
- CVKD 2023
- Fundamental
- Price
- POCI $4.73
- CVKD $12.05
- Analyst Decision
- POCI
- CVKD Strong Buy
- Analyst Count
- POCI 0
- CVKD 1
- Target Price
- POCI N/A
- CVKD $32.00
- AVG Volume (30 Days)
- POCI 19.0K
- CVKD 30.9K
- Earning Date
- POCI 05-15-2025
- CVKD 08-06-2025
- Dividend Yield
- POCI N/A
- CVKD N/A
- EPS Growth
- POCI N/A
- CVKD N/A
- EPS
- POCI N/A
- CVKD N/A
- Revenue
- POCI $17,626,155.00
- CVKD N/A
- Revenue This Year
- POCI N/A
- CVKD N/A
- Revenue Next Year
- POCI N/A
- CVKD N/A
- P/E Ratio
- POCI N/A
- CVKD N/A
- Revenue Growth
- POCI N/A
- CVKD N/A
- 52 Week Low
- POCI $3.47
- CVKD $5.70
- 52 Week High
- POCI $6.59
- CVKD $22.90
- Technical
- Relative Strength Index (RSI)
- POCI 56.28
- CVKD 41.92
- Support Level
- POCI $4.43
- CVKD $10.02
- Resistance Level
- POCI $5.00
- CVKD $13.30
- Average True Range (ATR)
- POCI 0.34
- CVKD 1.04
- MACD
- POCI 0.01
- CVKD -0.22
- Stochastic Oscillator
- POCI 77.01
- CVKD 34.22
About POCI Precision Optics Corporation Inc.
Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.